Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Seres Therapeutics, Inc. - Common Stock (NQ:MCRB)

14.90 +0.85 (+6.05%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 63,137
Open 14.08
Bid (Size) 14.45 (300)
Ask (Size) 15.80 (100)
Prev. Close 14.05
Today's Range 14.06 - 15.04
52wk Range 6.530 - 24.67
Shares Outstanding 127,901,391
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Seres (MCRB) Q3 2025 Earnings Call Transcript
Seres (MCRB) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Earnings Scheduled For November 5, 2025
 
Via Benzinga

Performance

YTD
-11.7%
-11.7%
1 Month
-22.5%
-22.5%
3 Month
-3.5%
-3.5%
6 Month
+102.2%
+102.2%
1 Year
+7.7%
+7.7%

More News

Read More
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Top movers in Monday's pre-market session
Via Chartmill
Earnings Scheduled For August 6, 2025
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
What's Next: Seres Therapeutics's Earnings Preview
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Seres (MCRB) Q2 Loss Narrows 34%
Via The Motley Fool
Seres Therapeutics Inc (NASDAQ:MCRB) Reports Q2 2025 Earnings: Narrower EPS Loss but Shares Dip in Pre-Market
Via Chartmill
Uncovering Potential: Seres Therapeutics's Earnings Preview
Via Benzinga
This Coty Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
Via Benzinga
Uber To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session.
Via Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Earnings Scheduled For March 13, 2025
Via Benzinga
What's going on in today's after hours session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Seres Therapeutics, Inc. - Common Stock publicly traded?
Yes, Seres Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Seres Therapeutics, Inc. - Common Stock trade on?
Seres Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Seres Therapeutics, Inc. - Common Stock?
The ticker symbol for Seres Therapeutics, Inc. - Common Stock is MCRB on the Nasdaq Stock Market
What is the current price of Seres Therapeutics, Inc. - Common Stock?
The current price of Seres Therapeutics, Inc. - Common Stock is 14.90
When was Seres Therapeutics, Inc. - Common Stock last traded?
The last trade of Seres Therapeutics, Inc. - Common Stock was at 11/11/25 04:00 PM ET
What is the market capitalization of Seres Therapeutics, Inc. - Common Stock?
The market capitalization of Seres Therapeutics, Inc. - Common Stock is 1.91B
How many shares of Seres Therapeutics, Inc. - Common Stock are outstanding?
Seres Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.